drugset / Trial / NCT05164627

Dexmedetomidine Versus Magnesium Infusion in Reducing Agitations in Pediatric Patients Undergoing Adenotonsillectomy

NCT05164627

Unknown 40 enrolled Ain Shams University
RandomizedParallel-groupOpen-labelPrevention

Summary

The aim of this study is evaluating the efficacy and safety of dexmedetomidine versus Magnesium for reducing emergence agitation after adenotonsillectomy in children. Secondary outcome is to reduce child needs for analgesics and to reduce their dose.

Timeline

Start
2021-01-08
Primary completion
2022-11-07
Completion
2022-12-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.2 ug/kg
Comparator Magnesium Sulfate Other / unclassified 10 mg/kg

Indications

No indication recorded.